Published by
TDPel Media
TDPel Media
The South African Health Products Regulatory Authority (SAHPRA) announced on Monday that it has registered the MC Pharma also known as Sinopharm COVID-19 vaccine. Initially developed by the Beijing Institute of Biological Products, the local drug watchdog said the Chinese two-dose COVID-19 jab is administered at an interval of two to four weeks apart. “This authorisation is based on acceptable safety, quality and efficacy data submitted by MC Pharma Pty (Ltd) to SAHPRA as a rolling submission over the period 23 July 2021 to 22 December 2021,” the organisation explained. In March last year, the…